Hepatobiliary Cancer Patients Social Determinants

Overview

About this study

The purpose of this study is to characterize the social determinants of health – and specifically travel-limiting access to cancer care but also other issues, such as trouble in finding childcare, joblessness, and limited education – among adults diagnosed with hepatobiliary cancers. In addition, we will also assess risk factors including aflatoxin exposure and hepatitis screening. The study involves administering a questionnaire to adults diagnosed hepatobiliary cancer patients and collect blood/buccal swab/urine for aflatoxin assessment.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • ≥ 18 years of age with hepatobiliary cancers and SEA American self-report (they or their family members are from/had been from Cambodia, Laos, or Vietnam) are eligible.
  • Newly diagnosed hepatobiliary cancers.

Exclusion Criteria: 

  • < 18 years of age. 

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/2/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nguyen Tran, M.D.

Open for enrollment

Contact information:

Nguyen Tran M.D.

(507) 284-2511

Tran.Nguyen@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20550309

Mayo Clinic Footer